Saltar al contenido

Clover Health Investments, Corp. (CLOV) stock: revenue, earnings & dividend

Clover Health Investments, Corp. (CLOV, Nasdaq): revenue, earnings, dividend and balance sheet from official SEC filings.

Stock screener CLOV · Nasdaq Versicherungen US

Key figures

Fiscal year
2025
Revenue
1.92 bn $
Revenue growth
40.3 %
Revenue growth 5y (p.a.)
23.4 %
Net income
-85.55 m $
Net margin
-4.5 %
Operating margin
-4.4 %
Earnings per share (diluted)
–
Dividend per share
–
Payout ratio
–
Consecutive dividend years
–
Consecutive dividend raises
–
Dividend growth 5y (p.a.)
–
Total assets
541 m $
Equity
309 m $
Equity ratio
57.1 %
Return on equity
-27.7 %
Cash
78.3 m $
Operating cash flow
-66.93 m $
Free cash flow
-68.98 m $
Shares outstanding
–

History

Revenue by fiscal year

2019 462 m $
2020 673 m $
2021 1.47 bn $
2022 1.1 bn $
2023 1.26 bn $
2024 1.37 bn $
2025 1.92 bn $

Net income by fiscal year

2019 -363.74 m $
2020 -136.39 m $
2021 -587.76 m $
2022 -338.84 m $
2023 -213.36 m $
2024 -43.01 m $
2025 -85.55 m $
YearRevenueNet incomeEPSDividend per shareOperating cash flow
20251.92 bn $-85.55 m $––-66.93 m $
20241.37 bn $-43.01 m $––34.8 m $
20231.26 bn $-213.36 m $-0.44 $–-144.66 m $
20221.1 bn $-338.84 m $-0.71 $–-203.93 m $
20211.47 bn $-587.76 m $-1.42 $–-282.33 m $
2020673 m $-136.39 m $-1.54 $–-118.5 m $
2019462 m $-363.74 m $-4.14 $–-159.88 m $

Data from XBRL filings at the SEC, processed automatically, no guarantee. Not investment advice. All filings at the SEC (EDGAR)